Nonresectable advanced or recurrent breast cancer previously treated with nonsteroidal aromatase inhibitor (AI), and planning to be treated with exemestane
You may not be if
Radiation therapy or immuno therapy within 14 days before the first dose of investigational product;
Chemotherapy, biological medicines, other pharmacotherapy or major surgery within 21 days before the first dose of the investigational product;
Prior chemotherapies of ≥ 3 regimens for advanced or recurrent breast cancer;
Ongoing treatment with other investigational product
Clareo Health | Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer
